Enterococcus faecalis
Antibiotic |
% Susceptible |
Antibiotic |
% Susceptible |
|
| Ampicillin | 99 |
Imipenem | + |
|
| Azithromycin | - |
Levofloxacin | 69 |
|
| Aztreonam | - |
Meropenem | +/- |
|
| Cefazolin | - |
Moxifloxacin | +
|
|
| Cefepime | - |
Nitrofurantoin | 98
|
|
| Ceftazidime | - |
Oxacillin/Naf | - |
|
| Ceftriaxone | - |
Penicillin | 99 |
|
| Cefuroxime | - |
Piperacillin | +
|
|
| Ciprofloxacin | 67 |
Piperacillin/tazo | + |
|
| Clarithromycin | - |
Ticarcillin/Clav | +/- |
|
| Clindamycin | - |
Tobramycin | S |
|
| Doxycycline | 24 |
TMP/SMX | - |
|
| Erythromycin | - |
Unasyn/Aug | + |
|
| Gentamicin | 78S |
Vancomycin | 100 |
|
Comments:
Numeric data represent local susceptibility data.
(+) = usually effective or >60% susceptible; (+/-) = clinical trials lacking or 30-60% susceptible; (-) = not effective clinically or <30% susceptible - Adapted with permission from The Sanford Guide to Antimicrobial Therapy 2007
(*) Local (non-Sanford Guide) opinion
(S) = synergistic with penicillin/ampicillin;
(&) nitrofurantoin only useful for lower tract urinary tract infections
(+) = usually effective or >60% susceptible; (+/-) = clinical trials lacking or 30-60% susceptible; (-) = not effective clinically or <30% susceptible - Adapted with permission from The Sanford Guide to Antimicrobial Therapy 2007
(*) Local (non-Sanford Guide) opinion
(S) = synergistic with penicillin/ampicillin;
(&) nitrofurantoin only useful for lower tract urinary tract infections